Jacky Vonderscher

Jacky Vonderscher is currently the CEO of Enyo Pharma (Lyon, France), a company he founded in 2013. Jacky is a recognized expert in exploratory research and early development. Prior to Enyo he spent five years as global Chairman of translational research sciences with Roche in Switzerland and the U.S. Prior to this he spent 30 years with Novartis in various R&D executive positions in the U.S and Europe, responsible for diverse global functions in exploratory research and new molecule early development and biomarkers. During this time he worked in collaboration with health agencies from the U.S (FDA), Europe (EMA) and Japan (PMDA) to validate 7 prognostic biomarkers/tests for renal disease. Jacky is a co-inventor on numerous novel medicine patents of which three went on to become marketed drugs.